National Health Investors Management
Management criteria checks 4/4
National Health Investors' CEO is D. Mendelsohn, appointed in Aug 2015, has a tenure of 8.75 years. total yearly compensation is $2.08M, comprised of 24% salary and 76% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth $3.51M. The average tenure of the management team and the board of directors is 6.7 years and 7.5 years respectively.
Key information
D. Mendelsohn
Chief executive officer
US$2.1m
Total compensation
| CEO salary percentage | 24.0% |
| CEO tenure | 8.8yrs |
| CEO ownership | 0.1% |
| Management average tenure | 6.7yrs |
| Board average tenure | 7.5yrs |
Recent management updates
Recent updates
National Health: Lots To Love, But Valuation Still On The High Side
Feb 23Catch The Senior Housing Rebound With National Health Investors
Nov 27National Health Investors: 7% Yielding REIT Has Improved On Most Metrics
Nov 13National Health Investors: Enjoy This Solid 7%+ Yield, For Now
Aug 30National Health: What We Got Wrong With This Healthcare REIT
Jun 14National Health Investors GAAP EPS of $0.04 misses by $0.65, revenue of $70.66M misses by $4.97M
Feb 216%-Yielding National Health Investors: No Pain, No Gain
Feb 06National Health Investors: Why This 5.5%-Yielding Rebound Is Worth A Shot
Sep 10National Health Investors Q2 Earnings Preview
Aug 07National Health Investors: A 5.8% Yield, And Little Else
Jun 29National Health Investors: Poor Price Growth, Steady Yield, Uncertain Future
Apr 14National Health Investors: Why This 7% Yielder Is A Buy On The Drop
Feb 06National Health Management Believes The 6.4% Yield Is Sustainable
Nov 17National Health Investors: Strong Fundamentals, Low Price, Long-Term Investment
Oct 11National Health Investors: Buy 'Em When They're Cheap
Sep 26National Health Investors: The Most Bearish Bull Thesis I Hope To Ever Write
Aug 31National Health: Not Out Of The Woods Yet
Aug 10National Health Investors reaches deferral agreement with Bickford
Jun 17National Health Investors invests $13.2M to expand Navion relationship
Jun 08National Health Investors invests $40.3M for Brookhaven Hospital acquisition
Jun 01Here's Why National Health Investors, Inc.'s (NYSE:NHI) CEO May Have Their Pay Bumped Up
Apr 28
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$2m | US$500k | US$136m |
| Sep 30 2023 | n/a | n/a | US$105m |
| Jun 30 2023 | n/a | n/a | US$110m |
| Mar 31 2023 | n/a | n/a | US$92m |
| Dec 31 2022 | US$3m | US$418k | US$66m |
| Sep 30 2022 | n/a | n/a | US$71m |
| Jun 30 2022 | n/a | n/a | US$68m |
| Mar 31 2022 | n/a | n/a | US$85m |
| Dec 31 2021 | US$3m | US$398k | US$112m |
| Sep 30 2021 | n/a | n/a | US$142m |
| Jun 30 2021 | n/a | n/a | US$154m |
| Mar 31 2021 | n/a | n/a | US$159m |
| Dec 31 2020 | US$2m | US$386k | US$185m |
| Sep 30 2020 | n/a | n/a | US$190m |
| Jun 30 2020 | n/a | n/a | US$190m |
| Mar 31 2020 | n/a | n/a | US$186m |
| Dec 31 2019 | US$2m | US$375k | US$160m |
| Sep 30 2019 | n/a | n/a | US$155m |
| Jun 30 2019 | n/a | n/a | US$154m |
| Mar 31 2019 | n/a | n/a | US$152m |
| Dec 31 2018 | US$2m | US$350k | US$154m |
| Sep 30 2018 | n/a | n/a | US$155m |
| Jun 30 2018 | n/a | n/a | US$153m |
| Mar 31 2018 | n/a | n/a | US$154m |
| Dec 31 2017 | US$2m | US$340k | US$159m |
Compensation vs Market: D.'s total compensation ($USD2.08M) is below average for companies of similar size in the US market ($USD6.67M).
Compensation vs Earnings: D.'s compensation has been consistent with company performance over the past year.
CEO
D. Mendelsohn (61 yo)
8.8yrs
Tenure
US$2,084,567
Compensation
Mr. D. Eric Mendelsohn has been a Director at National Health Investors, Inc since February 17, 2021. Mr. Mendelsohn serves as the Chief Executive Officer and President at National Health Investors Inc. si...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 8.8yrs | US$2.08m | 0.12% $ 3.5m | |
| Executive VP of Finance | 8.2yrs | US$1.30m | 0.042% $ 1.2m | |
| Executive VP & Chief Investment Officer | 7.3yrs | US$1.19m | 0.092% $ 2.6m | |
| Senior VP & Chief Accounting Officer | 4yrs | US$1.02m | 0.016% $ 453.0k | |
| Senior VP & Chief Transaction Officer | 1.3yrs | US$1.05m | 0.12% $ 3.3m | |
| Director of Investor Relations | 4.8yrs | no data | no data | |
| Director of Corporate Compliance & Human Resources | 9.3yrs | no data | no data | |
| Senior Vice President of Investments | 6.7yrs | no data | no data | |
| Corporate Secretary | no data | no data | no data | |
| Real Estate Transaction Manager | 4.8yrs | no data | no data |
6.7yrs
Average Tenure
51yo
Average Age
Experienced Management: NHI's management team is seasoned and experienced (6.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.3yrs | US$2.08m | 0.12% $ 3.5m | |
| Independent Chairman of the Board | 33.3yrs | US$175.86k | 1.97% $ 55.3m | |
| Independent Director | 4yrs | US$175.86k | 1.27% $ 35.6m | |
| Independent Director | 4yrs | US$175.86k | 0.25% $ 7.1m | |
| Independent Director | 23.3yrs | US$190.86k | 0.049% $ 1.4m | |
| Independent Director | 33.3yrs | US$180.86k | 0.24% $ 6.8m | |
| Independent Director | 1.9yrs | US$175.86k | 0% $ 0 | |
| Independent Director | 11.1yrs | US$180.86k | 0.036% $ 1.0m |
7.5yrs
Average Tenure
73.5yo
Average Age
Experienced Board: NHI's board of directors are considered experienced (7.5 years average tenure).